Drugs / NAL-GLU GnRH antagonist
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT00351416 Background | Jan 2004 → Jun 2009 | — | Massachusetts General Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NAL-GLU GnRH antagonist | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00351416 ↗ |
| Action | Inhibit | “The NAL-GLU GnRH antagonist is a drug that temporarily blocks the action of GnRH” NCT00351416 ↗ |
| Route | Subcutaneous | “5 mcg/kg of the NAL-GLU GnRH antagonist subcutaneously” NCT00351416 ↗ |